|

Hyperpolarized [1-13C] pyruvate (HP 13C) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Hyperpolarized 13C

Pipeline

Phase 2: 1

Top Sponsors

  • Ivan de Kouchkovsky, MD1

Indications

  • High Risk Prostate Carcinoma1
  • Prostate Cancer1
  • Cancer1

San Francisco, California1 trial

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

University of California, San Francisco

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.